Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Albrecht Claudio — Outlook Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Albrecht Claudio

Albrecht Claudio

Director at Outlook Therapeutics, Inc. · on record since Nov 2, 2017

Insider trading activity of Albrecht Claudio

Transactions on record: 1; since Nov 2, 2017

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Nov 2, 2017

Figures computed from official regulatory filings — methodology.

Companies where Albrecht Claudio has traded

Outlook Therapeutics, Inc.1 tx · Nov 2, 2017

Track record of Albrecht Claudio

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Albrecht Claudio

Co-insiders of Albrecht Claudio

Auffarth GerdOutlook Therapeutics, Inc.
Bahrt KennethOutlook Therapeutics, Inc.
Bao KoganOutlook Therapeutics, Inc.
Brady Todd COutlook Therapeutics, Inc.
Canute Scott AOutlook Therapeutics, Inc.
Dagnon TerryOutlook Therapeutics, Inc.
Dyrness Albert D.Outlook Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Evanson JeffOutlook Therapeutics, Inc.

Gangloff Scott A.Outlook Therapeutics, Inc.

Gangolli Julian SOutlook Therapeutics, Inc.

GMS Tenshi Holdings Pte. LtdOutlook Therapeutics, Inc.

GMS Ventures & InvestmentsOutlook Therapeutics, Inc.

Griffith Donald J.Outlook Therapeutics, Inc.

Haddadin Yezan MuntherOutlook Therapeutics, Inc.

Haller Julia AOutlook Therapeutics, Inc.

HILZINGER KURT JOutlook Therapeutics, Inc.

Huang AndongOutlook Therapeutics, Inc.

Jahr Robert CharlesOutlook Therapeutics, Inc.

KENYON LAWRENCE AOutlook Therapeutics, Inc.

MCANDREW STEPHEN JOutlook Therapeutics, Inc.

Mohan PankajOutlook Therapeutics, Inc.

Pillai Arun KumarOutlook Therapeutics, Inc.

Smith Hoke RobinOutlook Therapeutics, Inc.

Sukhtian Faisal GhiathOutlook Therapeutics, Inc.

Sukhtian Ghiath M.Outlook Therapeutics, Inc.

Syntone Ventures LLCOutlook Therapeutics, Inc.

Thomas JoeOutlook Therapeutics, Inc.

THURMAN RANDY HOutlook Therapeutics, Inc.

TRENARY C RUSSELL IIIOutlook Therapeutics, Inc.

Windisch JoergOutlook Therapeutics, Inc.

Yamashita Elizabeth A.Outlook Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Outlook Therapeutics, Inc.	Nov 2, 2017	AwardD	25,000	0.00 USD	$0	SEC